Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. (Q33688908)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. |
scientific article |
Statements
Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity (English)
David A Largaespada
Adrienne L Watson
Leah K Anderson
Andrew D Greeley
Eric P Rahrmann
Amanda L Halfond
Natasha M Powell
Margaret H Collins
Tilat Rizvi
Christopher L Moertel
1 reference
1 reference
1 reference
1 reference
1 reference